Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Dr Marian Knight from the University of Oxford has been awarded a National Institute for Health Research (NIHR) professorship, the Government has announced.

Marian KnightShe is one of eight researchers to receive the award, which recognises  the UK¹s most promising leaders in medical health research. 

The professors were selected by an international panel of experts following a competitive process open to candidates nationwide. Each professor will receive around £1.5m of funding for their research into a range of conditions that affect millions of patients across the UK. 
 
Dr Knight will use the funding for her research project, which aims to improve care for pregnant women and babies with life-threatening illnesses. 
 
Severe illnesses in pregnancy and early childhood can be devastating for parents and families,¹ said Dr Knight. ŒThis funding will be key to helping us work out how best to treat both pregnant women with life threatening illnesses and babies who require surgery in early life. 
 
Importantly, it will allow me to undertake new work investigating how children and their parents are affected by early surgery and the need for multiple hospital visits, and how we can make care better for them.¹ 
 
Health minister Anne Milton said: The professors will be given the opportunity to develop their research programmes, but most importantly they won't stop treating NHS patients. This will help make sure that new ideas make the leap from the bench to the bedside. We want to see medical research advance, and to do that it is essential that we nurture the very best researchers to the benefit of NHS patients.¹ 
 
Professor Dame Sally Davies, Chief Medical Officer and Chief Scientific Advisor at the Department of Health said: Each one of these professors already has an impressive track record, and I look forward to working with them in the future and seeing them flourish. They will provide much needed research leadership in their chosen field, and help us build more capacity and capability within the NIHR in very important areas. Our original intention was to appoint only five new research professors, but the international expert panel found the quality of applications so high that they advised eight awards should be made.¹ 
 
https://www.npeu.ox.ac.uk/staff/view/staff_19 
 
National Perinatal Epidemiology Unit 
 
National Institute for Health Research 

 

Similar stories

£100 million donation from Ineos to create new institute to fight antimicrobial resistance

Awards and Appointments General Innovation

A new state of the art institute for antimicrobial research is to open at Oxford University thanks to a £100 million donation from Ineos.

MRC HIU appoints new Director

Awards and Appointments General

We are pleased to announce that Professor Alison Simmons has been appointed as the new Director of the MRC Human Immunology Unit.

New Year's Honours 2021

Awards and Appointments General

Members of the Medical Sciences Division have been recognised in the New Year's Honours list for 2021.

Oxford University awarded £2.4 million to fund DPhil research in inflammation, immunology and musculoskeletal disease

Awards and Appointments General

Oxford University has been awarded a £2.4 million grant, as part of the Kennedy Trust MB PhD scheme, to fund undergraduate medical students to undertake DPhil research in the areas of inflammation, immunology and musculoskeletal disease.

Professor Sir Rory Collins awarded the MRC Millennium Medal 2020

Awards and Appointments General

Professor Sir Rory Collins, Head of the Nuffield Department of Population Health, and Principal Investigator and Chief Executive of UK Biobank, has been awarded the Medical Research Council (MRC) Millennium Medal 2020, the MRC’s most prestigious personal award.

University spinout PepGen awarded major financing to target Duchenne muscular dystrophy

Awards and Appointments General Innovation

PepGen, a therapeutics company targeting severe neuromuscular diseases, including Duchenne muscular dystrophy (DMD), has closed a $45 million Series A funding round led by RA Capital Management with participation from Oxford Sciences Innovation (OSI), the company’s original seed investor.